Home
Healthcare
Diagnostics & Biotech
Critical Care Diagnostics Market Size, Share & Growth [2031]

Critical Care Diagnostics Market

Name: Growth Market Reports
Address: 500 East E Street, Ontario, 91764, USA
Telephone: +1 909 414 1393

Segments - by Test Type (Routine & Special Chemistry, Flow Cytometry, Immunoproteins, Microbial & Infectious Diseases, and Others), Application (Operation Rooms, Emergency Rooms, and Intensive Care Units), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

HC-1008
4.7 Rating
159 Pages

Upcoming
81 Reviews

Author :

Raksha Sharma

Fact-checked by :

Vineet Pandey

Editor :

Vishal Golekar

Report Description

The global critical care diagnostics market size was USD 1.1 Bn in 2022 and is likely to reach USD 1.8 Bn by 2031, expanding at a CAGR of 5.6% during 2023–2031. The market growth is attributed to the increasing technological advancement and rising prevalence of infectious diseases and chronic disorders.

Critical care refers to the fulfillment of the requirement of patients who need immediate medical attention due to life-threatening health conditions. In such conditions, patients are usually facing the rapid deterioration of vital organs or are at risk of serious consequences.

Critical care diagnostics tests are extensively performed for intensive care and diagnosis of life-threatening diseases of patients. These tests are widely adopted due to certain advantages such as easy-to-use, rapid, and cost-effective with accurate results. Across the globe, critical care diagnostics are used in the operating room, emergency room, and intensive care units (ICUs).

Rising cases of serious illness, which require admission to the emergency room or urgent medical services present major driving factors for market expansion. As per global health data, around 20% of those who are admitted to hospitals are rushed to emergency rooms.

The rapid growth of various types of technological advancement is another major factor boosting the market. For instance, Abbott combines the i-Stat blood gas analyzer, and self-contained cartridges, with electrochemical detection and microfluidic components to give accurate and sensitive results.

The market report finds that the COVID-19 pandemic has negatively impacted the growth of the market. The implementation of lockdowns and transport bans has affected the production of medical equipment.

Critical Care Diagnostics Market Dynamics

The global critical care diagnostics market report has up-to-date insights that help in formulating a strategic roadmap about the estimated market scenario and performance during 2023 to 2031.

Drivers

Increasing awareness for early diagnosis and treatment among people and rapid development of accurate and cost-effective diagnostic tests are expected to boost the market growth. Wide adoption of data management and connectivity through inter-operability to electronic health records (EHR) is anticipated to push the market expansion. However, the increasing adoption of remote communications and the availability of advanced telehealth services are projected to drive the market growth in the coming years.

Restraints

The lack of skilled professionals for critical care diagnostics and the high cost of tests act as major challenges that can hamper the market expansion during the forecast period.

Opportunities

Ongoing extensive R&D activities to help develop several innovative diagnostic kits are anticipated to create lucrative opportunities for the market players.

Scope of Critical Care Diagnostics Market Report

The global critical care diagnostics market research report includes an assessment of the market trends, market segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Critical Care Diagnostics Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year	2022
Historic Data	2020–2021
Forecast Period	2023–2031
Segmentation	Test Type (Routine & Special Chemistry, Flow Cytometry, Immunoproteins, Microbial & Infectious Diseases, and Others), and Application (Operation Rooms, Emergency Rooms, and Intensive Care Units)
Regional Scope	Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast
Key Players Covered in the Report	Abbott.; Beckman Coulter, Inc.; BD.; Bayer AG; F. Hoffmann-La Roche Ltd; Siemens Healthcare GmbH; Bio-Rad Laboratories, Inc.; Chembio Diagnostics, Inc.; Nanōmix, Inc.; and Sysmex

Critical Care Diagnostics Market Segment Insights

Based on test type, the critical care diagnostics market is segmented into routine & special chemistry, flow cytometry, immunoproteins, microbial & infectious diseases, and others. The immunoproteins segment is expected to represent a key share of the market during the forecast period owing to increasing rapid and accurate diagnosis and also a reduction in the recovery time of patients.

Growing awareness about better healthcare among patients and increasing knowledge of physicians for target therapy are factors responsible for segment growth. Additionally, immunoprotein diagnostic tests are widely used for several applications to detect numerous health conditions that are related to a weakening immune system.

On the basis of application, the market is divided into operation rooms, emergency rooms, and intensive care units (ICUs). The emergency rooms segment is expected to expand at a rapid pace during the forecast period owing to the rising incidence of patients admitted for emergency services. Increasing use of advanced diagnostic tools in hospitals and continuous upgrades of emergency rooms to meet the needs of patients having immediate medical attention are likely to propel the segment growth.

In terms of region, the global critical care diagnostics market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the global market and is estimated to hold a large market share in the coming years. Key factors that fuel the regional market growth are the presence of major global players, the rising number of geriatric populations, and the early adoption of advanced technology of critical care diagnostic devices.

Asia Pacific is anticipated to expand at an impressive CAGR during the forecast period. The regional market growth can be attributed to improved healthcare infrastructure and a growing number of specialized hospitals for intensive care, especially in major economies such as India and China. Additionally, rising improvement of the primary healthcare systems and extended insurance coverage of patients are the new health reforms that boost the regional market growth.

Segments

The global critical care diagnostics market has been segmented on the basis of

Test Type

Routine & Special Chemistry
Flow Cytometry
Immunoproteins
Microbial & Infectious Diseases
Others

Application

Operation Rooms
Emergency Rooms
Intensive Care Uniits

Region

Asia Pacific
North America
Latin America
Europe
Middle East & Africa

Key Players

Abbott
Beckman Coulter, Inc.
BD.
Bayer AG
F. Hoffmann-La Roche Ltd
Siemens Healthcare GmbH
Bio-Rad Laboratories, Inc.
Chembio Diagnostics, Inc.
Nanōmix, Inc.
Sysmex

Competitive Landscape

Key players competing in the global critical care diagnostics market are Abbott.; Beckman Coulter, Inc.; BD.; Bayer AG; F. Hoffmann-La Roche Ltd; Siemens Healthcare GmbH; Bio-Rad Laboratories, Inc.; Chembio Diagnostics, Inc.; Nanōmix, Inc.; and Sysmex

These companies adopted development strategies including mergers, acquisitions, partnerships, collaboration, product launches, and production expansion to expand their consumer base worldwide.

In August 2020, Philips introduced a Rapid Equipment Deployment Kit for ICU ramp-ups. This kit provides hospitals with a way to quickly and easily expand their critical care capacity.

Critical Care Diagnostics Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Critical Care Diagnostics Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Critical Care Diagnostics Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Critical Care Diagnostics Market - Supply Chain
  4.5. Global Critical Care Diagnostics Market Forecast
     4.5.1. Critical Care Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Critical Care Diagnostics Market Size (000â€™ Units) and Y-o-Y Growth
     4.5.3. Critical Care Diagnostics Market Absolute $ Opportunity
5. Global Critical Care Diagnostics Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Critical Care Diagnostics Market Size and Volume Forecast by Applications
     5.3.1. Operation Rooms
     5.3.2. Emergency Rooms
     5.3.3. Intensive Care Uniits
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Critical Care Diagnostics Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Critical Care Diagnostics Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Critical Care Diagnostics Demand Share Forecast, 2019-2026
7. North America Critical Care Diagnostics Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Critical Care Diagnostics Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Critical Care Diagnostics Market Size and Volume Forecast by Applications
     7.4.1. Operation Rooms
     7.4.2. Emergency Rooms
     7.4.3. Intensive Care Uniits
  7.5. Basis Point Share (BPS) Analysis by Applications
  7.6. Y-o-Y Growth Projections by Applications
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Critical Care Diagnostics Demand Share Forecast, 2019-2026
8. Latin America Critical Care Diagnostics Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Critical Care Diagnostics Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Critical Care Diagnostics Market Size and Volume Forecast by Applications
     8.4.1. Operation Rooms
     8.4.2. Emergency Rooms
     8.4.3. Intensive Care Uniits
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Critical Care Diagnostics Demand Share Forecast, 2019-2026
9. Europe Critical Care Diagnostics Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Critical Care Diagnostics Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Critical Care Diagnostics Market Size and Volume Forecast by Applications
     9.4.1. Operation Rooms
     9.4.2. Emergency Rooms
     9.4.3. Intensive Care Uniits
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Critical Care Diagnostics Demand Share Forecast, 2019-2026
10. Asia Pacific Critical Care Diagnostics Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Critical Care Diagnostics Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Critical Care Diagnostics Market Size and Volume Forecast by Applications
     10.4.1. Operation Rooms
     10.4.2. Emergency Rooms
     10.4.3. Intensive Care Uniits
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Critical Care Diagnostics Demand Share Forecast, 2019-2026
11. Middle East & Africa Critical Care Diagnostics Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Critical Care Diagnostics Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Critical Care Diagnostics Market Size and Volume Forecast by Applications
     11.4.1. Operation Rooms
     11.4.2. Emergency Rooms
     11.4.3. Intensive Care Uniits
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Critical Care Diagnostics Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Critical Care Diagnostics Market: Market Share Analysis
  12.2. Critical Care Diagnostics Distributors and Customers
  12.3. Critical Care Diagnostics Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Abbott.
     12.4.2. Beckman Coulter, Inc.
     12.4.3. BD.
     12.4.4. Bayer AG
     12.4.5. F. Hoffmann-La Roche Ltd
     12.4.6. Siemens Healthcare GmbH
     12.4.7. Bio-Rad Laboratories, Inc.
     12.4.8. Chembio Diagnostics, Inc.
     12.4.9. Nanōmix, Inc.
     12.4.10. Sysmex

Methodology

Purchase Premium Report

Buy Now

Request For Sample

Request For Customization

Enquiry Before Buying

Speak With Analyst

Customize This Report

Ask for Research To Be Focused On Specific Regions or Segments
Receive Data As Per Your Format and Definition
Companies Profiled based on Your Requirements
Breaking Down Competitive Landscape as per Your Requirements
Any Level of Customization

Our Clients

Client Testinomials

We needed a highly accurate and precise report, which Growth Market Reports delivered promptly. The company compiled information from a wide array of reliable agencies and sourcess.It is extremely satisfactory to be working with you.
Strategy Head of Major Tech Company

We were very pleased to contact Growth Market Reports as they tailored reports precisely as per our requirements. As we are dealing with the aerospace and defense industry, we need reports of high accuracy and substantial quality.
Major Player in Defense Industry

Extremely delighted to have a well-crafted report on “Global Packaging Solutions Market Research Report” from your team. Thank you for providing me with all our requirements and for incorporating our suggestions.
CMO of Leading Packaging Company from USA

I had a good experience working with Growth Market Reports as they were very open to all constructive changes in the report. I found that the report had its charm embedded with ample of data.
Founder and Managing Partner of Major Korean Company

Our company has been working with Growth Market Reports for some years now and we are very happy with the quality of the reports provided by the company.I, on behalf of my organization, would like to thank you for offering professional reports.
Global Consulting Firm

Quick Contact

+1 909 414 1393

sales@growthmarketreports.com

Growth Market Report

Certified By

FAQ Section

Some frequently asked questions about this report!

1. How much is the global critical care diagnostics market size worth?

The global critical care diagnostics market size was valued at around USD 1.1 billion in 2022 and is likely to reach USD 1.8 billion by 2031.

2. What is the estimated compound annual growth rate (CAGR) of the critical care diagnostics market during the forecast period?

The global critical care diagnostics market is estimated to register a compound annual growth rate (CAGR) of around 5.6% during the forecast period.

3. Which region is likely to dominate the global critical care diagnostics market during the forecast period?

For region analysis, North America dominates the global critical care diagnostics market during the forecast period.

4. Who are the key players competing in the global critical care diagnostics market?

Some of the key global critical care diagnostics market players are Abbott.; Beckman Coulter, Inc.; BD.; Bayer AG; F. Hoffmann-La Roche Ltd; Siemens Healthcare GmbH; Bio-Rad Laboratories, Inc.; Chembio Diagnostics, Inc.; Nanōmix, Inc.; and Sysmex